-
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care
b3cnewswire
June 27, 2019
MammaPrint® Becomes Only Molecular Diagnostic Recommended for Early-Stage Node-Positive Breast Cancer Patients in ASCO-Endorsed Cancer Care Ontario Guidelines.
-
Cancer Survivors Have High Prevalence of Chronic Pain
drugs
June 26, 2019
Cancer Survivors Have High Prevalence of Chronic Pain.
-
Drug Combo Slows Progression in Advanced Breast Cancer
drugs
June 25, 2019
Drug Combo Slows Progression in Advanced Breast Cancer.
-
Could 3-D Mammograms Soon Be the Standard for Breast Cancer Screening?
drugs
June 25, 2019
Could 3-D Mammograms Soon Be the Standard for Breast Cancer Screening?
-
Better Treatments Needed to Boost Brain Cancer Survival: Study
drugs
June 24, 2019
Glioblastoma brain cancer remains one of deadliest tumors, and new research shows five-year survival rates remain low for patients with the disease.
-
Heart Disease Is Lasting Threat to Breast Cancer Survivors
drugs
June 24, 2019
Heart Disease Is Lasting Threat to Breast Cancer Survivors.
-
Poor Oral Health Not Linked to Gastrointestinal Cancer Risk
drugs
June 24, 2019
Poor Oral Health Not Linked to Gastrointestinal Cancer Risk.
-
Seniors Who Develop Cancer Have Better Memory, Slower Decline
drugs
June 24, 2019
Seniors Who Develop Cancer Have Better Memory, Slower Decline.
-
Lynparza has been approved for BRCA-mutated advanced ovarian cancer
europeanpharmaceuticalreview
June 24, 2019
BRCA-mutated advanced ovarian cancer treatment has been approved by the European Commission.
-
More Than 5 Million U.S. Cancer Survivors Deal With Chronic Pain
drugs
June 21, 2019
More Than 5 Million U.S. Cancer Survivors Deal With Chronic Pain.